Petri Bono
MD, PhD, Member of the Scientific Advisory Board
Petri Bono serves as the Chief Medical Officer and part of the executive team of Terveystalo, the largest healthcare service company in Finland. Prior to Terveystalo he was the Chief Medical Officer at Helsinki University Hospital. In addition, Dr. Bono has held various leadership positions within Helsinki University Hospital, including as the Director and Physician-in-Chief of the Comprehensive Cancer Center. Dr Bono’s own research has been focused in many areas of molecular and immunological oncology. Given his PhD in basic and applied immunology, he is uniquely suited to support TILT’s immuno-oncology programs forward clinically. Dr Bono has participated in numerous clinical trials including early phase immuno-oncological trials and published 60 peer reviewed papers in international journals.
